Skip to main content

Advertisement

Log in

Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis

  • Original Paper
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The objective of this study was to investigate the expression of IL-23 and IL-17 and the influence of IL-23 on IL-17 production in ankylosing spondylitis (AS) patients. IL-23 and IL-17 levels in the serum and supernatants of cultured peripheral blood mononuclear cells (PBMCs) were determined by ELISA. IL-23p19 mRNA expression in PBMCs were analyzed using RT-PCR. The patients with AS at active stage showed elevated levels of IL-23 and IL-17 in the serum and supernatants of cultured PBMCs. A higher expression of IL-23p19 mRNA in PBMCs of AS patients was also observed. A significantly enhanced production of IL-17 in the supernatants of cultured PBMCs was found in the presence of recombinant IL-23 and this effect was more significant in patients with AS. The results suggest that IL-23 and IL-17 may play critical roles in the pathogenesis of AS and IL-23-stimulated production of IL-17 by PBMCs may be responsible for the development of AS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Oppmann B, Lesley R, Blom B et al (2000) Novel p19 protein engages IL-12p40 to form a cytokine from a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715–725. doi:10.1016/S1074-7613(00)00070-4

    Article  PubMed  CAS  Google Scholar 

  2. Lee E, Trepicchio WL, Oestreicher JL et al (2004) Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 199:125–130. doi:10.1084/jem.20030451

    Article  PubMed  CAS  Google Scholar 

  3. Pirhonen J, Matikainen S, Julkunen I (2002) Regulation of virus-induced IL-12 and IL-23 expression in human macrophages. J Immunol 169:5673–5678

    PubMed  CAS  Google Scholar 

  4. van Seventer JM, Nagai T, van Seventer GA (2002) Interferon-beta differentially regulates expression of the IL-12 family members p35, p40, p19 and EBI3 in activated human dendritic cells. J Neuroimmunol 133:60–71. doi:10.1016/S0165-5728(02)00362-4

    Article  PubMed  Google Scholar 

  5. Cua DJ, Sherlock J, Chen Y et al (2003) Inerleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744–748. doi:10.1038/nature01355

    Article  PubMed  CAS  Google Scholar 

  6. Yen D, Cheung J, Scheerens H et al (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116:1310–1316. doi:10.1172/JCI21404

    Article  PubMed  CAS  Google Scholar 

  7. Lew W, Chang JY, Jung JY et al (2008) Increased expression of interleukin-23 p19 mRNA in erythema nodosum-like lesions of Behcet’s disease. Br J Dermatol 158:505–511. doi:10.1111/j.1365-2133.2007.08403.x

    Article  PubMed  CAS  Google Scholar 

  8. Chabaud M, Durand JM, Buchs N et al (1999) Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42:963–970. doi:10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E

    Article  PubMed  CAS  Google Scholar 

  9. Kotake S, Udagawa N, Takahashi N et al (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103:1345–1352. doi:10.1172/JCI5703

    Article  PubMed  CAS  Google Scholar 

  10. Wong CK, Ho CY, Li EK et al (2000) Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9:589–593. doi:10.1191/096120300678828703

    Article  PubMed  CAS  Google Scholar 

  11. Kurasawa K, Hirose K, Sano H et al (2000) Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum 43:2455–2463. doi:10.1002/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K

    Article  PubMed  CAS  Google Scholar 

  12. Teunissen MB, Koomen CW, l Malefyt R et al (1998) Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol 111:645–649. doi:10.1046/j.1523-1747.1998.00347.x

    Article  PubMed  CAS  Google Scholar 

  13. Lowes MA, Kikuchi T, Fuentes-Duculan J et al (2008) Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 128:1207–1211. doi:10.1038/sj.jid.5701213

    Article  PubMed  CAS  Google Scholar 

  14. Fujino S, Andoh A, Bamba S et al (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52:65–70. doi:10.1136/gut.52.1.65

    Article  PubMed  CAS  Google Scholar 

  15. McKenzie BS, Kastelein R, Cua DJ (2006) Understanding the IL-23-IL-17 immune pathway. Trends Immunol 27:17–23. doi:10.1016/j.it.2005.10.003

    Article  PubMed  CAS  Google Scholar 

  16. Langrish CL, Chen Y, Blumenschein WM et al (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201:233–240. doi:10.1084/jem.20041257

    Article  PubMed  CAS  Google Scholar 

  17. Murphy CA, Langrish CL, Chen Y et al (2003) Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198:1951–1957. doi:10.1084/jem.20030896

    Article  PubMed  CAS  Google Scholar 

  18. Chen Y, Langrish CL, McKenzie BS et al (2006) Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 116:1317–1326. doi:10.1172/JCI25308

    Article  PubMed  CAS  Google Scholar 

  19. Nakae S, Nambu A, Sudo K, Iwakura Y (2003) Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171:6173–6177

    PubMed  CAS  Google Scholar 

  20. Lubberts E, Koenders MI, Oppers-Walgreen B et al (2004) Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50:650–659. doi:10.1002/art.20001

    Article  PubMed  CAS  Google Scholar 

  21. Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369:1379–1390. doi:10.1016/S0140-6736(07)60635-7

    Article  PubMed  Google Scholar 

  22. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368. doi:10.1002/art.1780270401

    Article  PubMed  Google Scholar 

  23. Ma XT, Zhang XJ, Zhang B et al (2004) Expression and regulation of interleukin-23 subunits in human peripheral blood mononuclear cells and hematopoietic cell lines in response to various inducers. Cell Biol Int 28:689–697. doi:10.1016/j.cellbi.2004.07.002

    Article  PubMed  CAS  Google Scholar 

  24. Iwakura Y, Ischigame H (2006) The IL-23/IL-17 axis in inflammation. J Clin Invest 116:1218–1222. doi:10.1172/JCI28508

    Article  PubMed  CAS  Google Scholar 

  25. Dong C (2006) Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat Rev Immunol 6:329–333. doi:10.1038/nri1807

    Article  PubMed  CAS  Google Scholar 

  26. Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21:467–476. doi:10.1016/j.immuni.2004.08.018

    Article  PubMed  CAS  Google Scholar 

  27. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL (2003) Interleukin-23 promotes a distinct CD4 T-cell activation state characterized by the production of interleukin-17. J Biol Chem 278:1910–1914. doi:10.1074/jbc.M207577200

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by research grant 30325019 of National Science in China.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jieruo Gu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, X., Lin, Z., Wei, Q. et al. Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis. Rheumatol Int 29, 1343–1347 (2009). https://doi.org/10.1007/s00296-009-0883-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-009-0883-x

Keywords

Navigation